Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial
Peter B. Gilbert, David C. Montefiori, Adrian McDermott, Youyi Fong, View ORCID ProfileDavid Benkeser, Weiping Deng, Honghong Zhou, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Britta Flach, Bob C. Lin, Sarah O’Connell, Charlene McDanal, Amanda Eaton, Marcella Sarzotti-Kelsoe, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima Hejazi, Chuong Huynh, Jacqueline Miller, View ORCID ProfileHana M. El Sahly, Lindsey R. Baden, Mira Baron, Luis De La Cruz, Cynthia Gay, Spyros Kalams, Colleen F. Kelley, Mark Kutner, Michele P. Andrasik, James G. Kublin, Lawrence Corey, Kathleen M. Neuzil, View ORCID ProfileLindsay N. Carpp, Rolando Pajon, Dean Follmann, Ruben O. Donis, Richard A. Koup on behalf of the Immune Assays; Moderna, Inc.; Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE); and United States Government (USG)/CoVPN Biostatistics Teams
doi: https://doi.org/10.1101/2021.08.09.21261290
Peter B. Gilbert
1The Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
David C. Montefiori
4National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; the Department of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC
Adrian McDermott
2The Vaccine Research Center
Youyi Fong
1The Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
David Benkeser
5The Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA
Weiping Deng
8Moderna, Inc., Cambridge, MA
Honghong Zhou
8Moderna, Inc., Cambridge, MA
Christopher R. Houchens
6The Biomedical Advanced Research and Development Authority, Washington, DC
Karen Martins
6The Biomedical Advanced Research and Development Authority, Washington, DC
Lakshmi Jayashankar
6The Biomedical Advanced Research and Development Authority, Washington, DC
Flora Castellino
6The Biomedical Advanced Research and Development Authority, Washington, DC
Britta Flach
2The Vaccine Research Center
Bob C. Lin
2The Vaccine Research Center
Sarah O’Connell
2The Vaccine Research Center
Charlene McDanal
4National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; the Department of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC
Amanda Eaton
4National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; the Department of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC
Marcella Sarzotti-Kelsoe
4National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; the Department of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC
Yiwen Lu
1The Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Chenchen Yu
1The Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Bhavesh Borate
1The Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Lars W. P. van der Laan
1The Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Nima Hejazi
7Graduate Group in Biostatistics, University ofBerkeley, Berkeley, CA
Chuong Huynh
6The Biomedical Advanced Research and Development Authority, Washington, DC
Jacqueline Miller
8Moderna, Inc., Cambridge, MA
Hana M. El Sahly
9Baylor College of Medicine, Houston, TX
Lindsey R. Baden
10Brigham and Women’s Hospital, Boston, MA
Mira Baron
11Palm Beach Research Center, West Palm Beach, FL
Luis De La Cruz
12Keystone Vitalink Research, Greenville, SC
Cynthia Gay
13University of North Carolina, Chapel Hill, NC
Spyros Kalams
14Vanderbilt University Medical Center, Nashville, TN
Colleen F. Kelley
15Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine and the Grady Health System, Atlanta, GA
Mark Kutner
16Suncoast Research Group, Miami, FL
Michele P. Andrasik
1The Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
James G. Kublin
1The Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Lawrence Corey
1The Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Kathleen M. Neuzil
17The Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD
Lindsay N. Carpp
1The Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
Rolando Pajon
8Moderna, Inc., Cambridge, MA
Dean Follmann
3The Biostatistics Research Branch
Ruben O. Donis
6The Biomedical Advanced Research and Development Authority, Washington, DC
Richard A. Koup
2The Vaccine Research Center
Data Availability
As the trial is ongoing, access to patient-level data and supporting clinical documents with qualified external researchers may be available upon request and subject to review once the trial is complete.
Posted August 15, 2021.
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial
Peter B. Gilbert, David C. Montefiori, Adrian McDermott, Youyi Fong, David Benkeser, Weiping Deng, Honghong Zhou, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Britta Flach, Bob C. Lin, Sarah O’Connell, Charlene McDanal, Amanda Eaton, Marcella Sarzotti-Kelsoe, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima Hejazi, Chuong Huynh, Jacqueline Miller, Hana M. El Sahly, Lindsey R. Baden, Mira Baron, Luis De La Cruz, Cynthia Gay, Spyros Kalams, Colleen F. Kelley, Mark Kutner, Michele P. Andrasik, James G. Kublin, Lawrence Corey, Kathleen M. Neuzil, Lindsay N. Carpp, Rolando Pajon, Dean Follmann, Ruben O. Donis, Richard A. Koup
medRxiv 2021.08.09.21261290; doi: https://doi.org/10.1101/2021.08.09.21261290
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial
Peter B. Gilbert, David C. Montefiori, Adrian McDermott, Youyi Fong, David Benkeser, Weiping Deng, Honghong Zhou, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Britta Flach, Bob C. Lin, Sarah O’Connell, Charlene McDanal, Amanda Eaton, Marcella Sarzotti-Kelsoe, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima Hejazi, Chuong Huynh, Jacqueline Miller, Hana M. El Sahly, Lindsey R. Baden, Mira Baron, Luis De La Cruz, Cynthia Gay, Spyros Kalams, Colleen F. Kelley, Mark Kutner, Michele P. Andrasik, James G. Kublin, Lawrence Corey, Kathleen M. Neuzil, Lindsay N. Carpp, Rolando Pajon, Dean Follmann, Ruben O. Donis, Richard A. Koup
medRxiv 2021.08.09.21261290; doi: https://doi.org/10.1101/2021.08.09.21261290
Subject Area
Subject Areas
- Addiction Medicine (241)
- Allergy and Immunology (521)
- Anesthesia (125)
- Cardiovascular Medicine (1425)
- Dermatology (158)
- Emergency Medicine (292)
- Epidemiology (10307)
- Gastroenterology (528)
- Genetic and Genomic Medicine (2637)
- Geriatric Medicine (254)
- Health Economics (497)
- Health Informatics (1740)
- Health Policy (790)
- Hematology (268)
- HIV/AIDS (568)
- Medical Education (273)
- Medical Ethics (83)
- Nephrology (291)
- Neurology (2466)
- Nursing (145)
- Nutrition (379)
- Oncology (1327)
- Ophthalmology (403)
- Orthopedics (147)
- Otolaryngology (238)
- Pain Medicine (168)
- Palliative Medicine (51)
- Pathology (343)
- Pediatrics (784)
- Primary Care Research (296)
- Public and Global Health (5018)
- Radiology and Imaging (895)
- Respiratory Medicine (682)
- Rheumatology (309)
- Sports Medicine (246)
- Surgery (298)
- Toxicology (45)
- Transplantation (141)
- Urology (108)